Stocks and Investing Stocks and Investing
Wed, April 4, 2018
Tue, April 3, 2018
Mon, April 2, 2018

Geoff Meacham Initiated (BTAI) at Buy and Held Target at $15 on, Apr 2nd, 2018


Published on 2024-10-26 04:12:43 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Buy and Held Target at $15 on, Apr 2nd, 2018.

Geoff, nor any peers, have made any analyst calls on BTAI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources